L&M Healthcare Communications, LLC

Based in the US, L&M Healthcare Communications specializes in healthcare marketing, providing innovative communication solutions tailored to the biotech, medical device, and pharmaceutical industries. L&M Healthcare Communications, LLC, established in 2005, focuses on delivering targeted healthcare communication solutions. The company is headquartered in the US and has undergone a strategic transformation, rebranding as Fingerpaint Medical. In November 2025, Fingerpaint Group, a portfolio company of Knox Lane, acquired L&M Healthcare Communications, further enhancing market reach and capabilities.

The founder's history is not available. L&M Healthcare, now rebranded as Fingerpaint Medical, offers a comprehensive suite of medical communication and marketing services aimed at the biotech, medical device, and pharmaceutical sectors. Their core products include the Speaker Tracking and Reporting System (STARS), a cloud-based platform that centralizes program management, and a Speakers Bureau that facilitates peer-to-peer education among healthcare professionals. With over 17 years of experience, L&M specializes in creating scientifically-driven communication programs that educate and engage key stakeholders, ensuring that medical advancements reach the appropriate audiences.

Their services extend across various geographical markets, including North America and Europe, where they serve clients ranging from large pharmaceutical companies to emerging biotech firms, ultimately impacting healthcare professionals and patients who benefit from improved access to medical information. The revenue structure of Fingerpaint Medical involves multiple transaction types, primarily centered around B2B partnerships with pharmaceutical and biotech companies. Clients engage the firm for services related to program development, compliance management, and content creation, which may be structured as project-based contracts or annual retainer agreements. These engagements often include comprehensive service packages that encompass the planning and execution of educational programs, speaker training, and advisory board support.

While specific pricing details are proprietary, the firm’s flagship offerings are tailored to meet the unique needs of each client, with costs reflecting the complexity and scope of the services provided. In November 2025, Fingerpaint Group acquired L&M Healthcare Communications, enabling an expansion of its portfolio and market access capabilities. The company plans to leverage recent funding to enhance its service offerings and enter new markets. Future initiatives include launching new products tailored for the biotech and pharmaceutical sectors.

Specific expansion targets include broader reach into European markets, with anticipated developments to unfold by late 2026.